Triple-negative breast cancer: MRI features in 29 patients [2]

Annals of Oncology

Volumn 18, Issue 12, 2007, Pages 2042-2043

  Chen, J H ^a,b   Agrawal, G ^a   Feig, B ^a   Baek, H M ^a   Carpenter, P M ^c   Mehta, R S ^c   Nalcioglu, O ^a   Su, M Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GADODIAMIDE;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LETTER; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 37349000391     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm504     Document Type: Letter

References (7)

1. Haffty BG, Yang Q, Reiss M et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 2006; 24 (36): 5652-5657.
2. Rakha EA, El-Sayed ME, Green AR et al. Prognostic markers in triple-negative breast cancer. Cancer 2007; 109 (1): 25-32.
3. Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol 2007; 8 (3): 235-244.
4. Carey LA, Perou CM, Livasy CA et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295: 2492-2502.
5. Bauer KR, Brown M, Cress RD et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry. Cancer 2007; 109 (9): 1721-1728.
6. Siziopikou KP, Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast. 2007; 16 (1): 104-107.
7. American College of Radiology. Breast Imaging Reporting and Data System Atlas (BI-RADS aflas). Reston, VA: American College of Radiology, 2003.